Vaccitech
Achelya Ozyigit has work experience as an Associate Scientist at Vaccitech since July 2022. Prior to that, they worked as a Research Student at Kidscan Children's Cancer Research from September 2020 to August 2021. Achelya also served as an Intern at Dr. Burhan Nalbantoglu State Hospital in August and September 2019, and as an Intern at Erduran Laboratory in February and March 2016.
Achelya Ozyigit attended The University of Salford from 2018 to 2022, where they pursued a Bachelor of Science degree in Biomedical Science with Professional Experience.
This person is not in any offices
Vaccitech
1 followers
Vaccitech is a clinical stage T cell immunotherapy company developing products to treat and prevent cancer and infectious diseases. The company’s proprietary technology platform, comprising Chimpanzee Adenovirus (prime) and MVA (boost) is exceptional at inducing, boosting and maintaining CD8+ and CD4+ T cells, as well as antibodies.